ai-research-survey

scan-v4.json (31076B)

---

 {
   "scan_version": 4,
   "paper_type": "empirical",
   "paper": {
     "title": "Beyond Benchmarks: The Economics of AI Inference",
     "authors": [
       "Boqin Zhuang",
       "Jiacheng Qiao",
       "Mingqian Liu",
       "Mingxing Yu",
       "Ping Hong",
       "Rui Li",
       "Xiaoxia Song",
       "Xiangjun Xu",
       "Xu Chen",
       "Yaoyao Ma",
       "Yujie Gao"
     ],
     "year": 2025,
     "venue": "arXiv",
     "arxiv_id": "2510.26136",
     "doi": null
   },
   "checklist": {
     "claims_and_evidence": {
       "abstract_claims_supported": {
         "applies": true,
         "answer": true,
         "justification": "The abstract claims about diminishing marginal cost, diminishing returns to scale, and an optimal cost-effectiveness zone are supported by the concurrency data in Appendix B and the Pareto frontier in Figure 1.",
         "source": "opus"
       },
       "causal_claims_justified": {
         "applies": true,
         "answer": false,
         "justification": "The paper makes causal claims like 'increasing concurrency is the most effective way to amortize fixed overhead' (Section 6.1) without controlling for confounds. The concurrency-cost relationship is presented as causal without experimental isolation.",
         "source": "opus"
       },
       "generalization_bounded": {
         "applies": true,
         "answer": false,
         "justification": "The paper claims to provide 'the first quantifiable decision-making tool for selecting the best AI technology within a limited budget' (Section 8) but all results are from a single medical benchmark (WiNEval-3.0) on A800 GPUs. The title 'The Economics of AI Inference' is far broader than what was tested.",
         "source": "opus"
       },
       "alternative_explanations_discussed": {
         "applies": true,
         "answer": false,
         "justification": "No alternative explanations are considered. For example, the paper does not discuss whether WiNGPT-3.5's high score could be due to training on similar medical data, or whether tokenizer efficiency differences confound cost comparisons.",
         "source": "opus"
       },
       "proxy_outcome_distinction": {
         "applies": true,
         "answer": false,
         "justification": "WiNEval-3.0 score is used as a proxy for 'quality' and 'intelligence' without acknowledging the gap. The paper equates benchmark performance with clinical utility: 'the core quality metric to measure a model's comprehensive abilities in medical knowledge understanding, clinical reasoning, and instruction following' (Section 5.2) but does not discuss whether benchmark scores translate to real clinical value.",
         "source": "opus"
       }
     },
     "limitations_and_scope": {
       "limitations_section_present": {
         "applies": true,
         "answer": true,
         "justification": "Section 7 'Limitations' lists five specific limitations including exclusion of training costs, hardware dependency, proxy nature of benchmarks, lack of statistical confidence analysis, and capital expenditure considerations.",
         "source": "opus"
       },
       "threats_to_validity_specific": {
         "applies": true,
         "answer": true,
         "justification": "The limitations are specific to this study: 'Changing the GPU, inference engine, or quantization strategy could significantly alter the performance and cost data' (Limitation 2), and 'WiNEval-3.0 serves as a high-quality proxy metric... not entirely equivalent to a model's final performance in specific, specialized clinical business scenarios' (Limitation 3).",
         "source": "opus"
       },
       "scope_boundaries_stated": {
         "applies": true,
         "answer": true,
         "justification": "Section 7 explicitly states training costs are not included (Limitation 1), results depend on specific hardware (Limitation 2), and upfront capital expenditure is not considered (Limitation 5).",
         "source": "opus"
       }
     },
     "conflicts_of_interest": {
       "funding_disclosed": {
         "applies": true,
         "answer": false,
         "justification": "No funding disclosure or acknowledgments section is present in the paper.",
         "source": "opus"
       },
       "affiliations_disclosed": {
         "applies": true,
         "answer": true,
         "justification": "Authors are identified as 'WiNGPT Team' from 'Winning Health AI Research' in the header. The affiliation is clear.",
         "source": "opus"
       },
       "funder_independent_of_outcome": {
         "applies": true,
         "answer": false,
         "justification": "Winning Health is the developer of the WiNGPT model family. They are directly evaluating their own commercial products using their own proprietary benchmark, and their model (WiNGPT-3.5) is declared the winner. The funder/employer has a direct financial interest in the outcome.",
         "source": "opus"
       },
       "financial_interests_declared": {
         "applies": true,
         "answer": false,
         "justification": "No competing interests statement is present. The authors work for the company whose products are being favorably evaluated.",
         "source": "opus"
       }
     },
     "scope_and_framing": {
       "key_terms_defined": {
         "applies": true,
         "answer": true,
         "justification": "Key terms defined: Performance (Table 1: TTFT, throughput, total time), Quality (section 5.2: WiNEval-3.0 score), Cost (equations 2-4: hourly GPU cost, test set cost). Some terms implicit but defined in context (Pareto frontier assumed from Figure 1).",
         "source": "haiku"
       },
       "intended_contribution_clear": {
         "applies": true,
         "answer": true,
         "justification": "Contribution explicitly stated in abstract: 'introduces a quantitative economics of inference framework.' Section 6 lists three applications: GPU procurement planning, model selection for tasks, concurrency optimization. Reader knows what paper claims to deliver.",
         "source": "haiku"
       },
       "engagement_with_prior_work": {
         "applies": true,
         "answer": false,
         "justification": "Only 8 references total, no related work section. Citations listed (Brown et al., Touvron et al., Zheng et al.) but not discussed. No comparison to prior economics analyses, no positioning relative to existing cost-quality frameworks. Prior work treated as bibliography, not conversation.",
         "source": "haiku"
       }
     }
   },
   "type_checklist": {
     "empirical": {
       "artifacts": {
         "code_released": {
           "applies": true,
           "answer": false,
           "justification": "No repository URL, code archive, or link to source code is provided anywhere in the paper.",
           "source": "opus"
         },
         "data_released": {
           "applies": true,
           "answer": false,
           "justification": "WiNEval-3.0 is described as a proprietary medical evaluation set from Winning Health. No download link or public access is provided.",
           "source": "opus"
         },
         "environment_specified": {
           "applies": true,
           "answer": false,
           "justification": "The paper states 'A800 80G × 2 cards' but provides no software environment details — no inference framework version, OS, driver version, or dependency specifications.",
           "source": "opus"
         },
         "reproduction_instructions": {
           "applies": true,
           "answer": false,
           "justification": "No reproduction instructions, README, or scripts are provided. The benchmark is proprietary and unavailable.",
           "source": "opus"
         }
       },
       "statistical_methodology": {
         "confidence_intervals_or_error_bars": {
           "applies": true,
           "answer": false,
           "justification": "All results are point estimates. No confidence intervals or error bars are reported in any table or figure.",
           "source": "opus"
         },
         "significance_tests": {
           "applies": true,
           "answer": false,
           "justification": "The paper claims WiNGPT-3.5 is the 'overall leader' and makes comparative claims across models, but no statistical significance tests are performed.",
           "source": "opus"
         },
         "effect_sizes_reported": {
           "applies": true,
           "answer": true,
           "justification": "Table 2 reports absolute cost and score values with enough context to compute differences (e.g., WiNGPT-3.5 at $0.34/76.2 vs Seed-OSS-36B at $0.55/72.2). Appendix B shows performance changes across concurrency levels with absolute values.",
           "source": "opus"
         },
         "sample_size_justified": {
           "applies": true,
           "answer": false,
           "justification": "The benchmark has 2,993 requests but no justification is given for why this number is sufficient. No power analysis or discussion of statistical adequacy.",
           "source": "opus"
         },
         "variance_reported": {
           "applies": true,
           "answer": false,
           "justification": "The paper acknowledges 'slight fluctuations' from model randomness and vLLM scheduling but reports no standard deviation, variance, or multiple-run statistics. Single-run results only.",
           "source": "opus"
         }
       },
       "evaluation_design": {
         "baselines_included": {
           "applies": true,
           "answer": true,
           "justification": "Nine models are compared including WiNGPT variants, Qwen3-30B, GLM-4-32B, Mistral-Small, medgemma-27b, Seed-OSS-36B, and gpt-oss-20b (Table 2).",
           "source": "opus"
         },
         "baselines_contemporary": {
           "applies": true,
           "answer": true,
           "justification": "Models include Qwen3-30B, GLM-4-32B-0414, medgemma-27b, and Mistral-Small, which are contemporary as of 2025.",
           "source": "opus"
         },
         "ablation_study": {
           "applies": true,
           "answer": false,
           "justification": "No ablation study is conducted. The framework has multiple components (cost model, performance metrics, quality score) but none are ablated.",
           "source": "opus"
         },
         "multiple_metrics": {
           "applies": true,
           "answer": true,
           "justification": "Three performance metrics (Total Completion Time, Avg TTFT, Avg Throughput) plus quality score and cost are reported (Table 1, Table 2).",
           "source": "opus"
         },
         "human_evaluation": {
           "applies": false,
           "answer": false,
           "justification": "The paper benchmarks inference economics — human evaluation of model outputs is not the focus. Quality is measured via WiNEval-3.0 automated scoring.",
           "source": "opus"
         },
         "held_out_test_set": {
           "applies": true,
           "answer": false,
           "justification": "WiNEval-3.0 is described only as a test set. No discussion of held-out vs. development splits, or whether any models were tuned on this data.",
           "source": "opus"
         },
         "per_category_breakdown": {
           "applies": true,
           "answer": false,
           "justification": "WiNEval-3.0 covers '10 core scenarios' (medical licensing exams, clinical diagnosis, etc.) but no per-category breakdown of scores is provided. Only aggregate scores appear in Table 2.",
           "source": "opus"
         },
         "failure_cases_discussed": {
           "applies": true,
           "answer": false,
           "justification": "No failure cases or error analysis are discussed. No examples of model failures on specific tasks.",
           "source": "opus"
         },
         "negative_results_reported": {
           "applies": true,
           "answer": true,
           "justification": "The paper reports that increasing concurrency beyond the optimal point causes throughput to drop sharply and TTFT to increase (Section 6.1 point 2). WiNGPT-3.0's extreme cost ($3.47) is discussed honestly as an outlier.",
           "source": "opus"
         }
       },
       "setup_transparency": {
         "model_versions_specified": {
           "applies": true,
           "answer": false,
           "justification": "Models are listed as 'WiNGPT-3.5', 'Qwen3-30B', 'GLM-4-32B-0414', etc. GLM includes a version suffix but most models lack snapshot dates or exact version identifiers. Parameter counts are given but not specific checkpoints.",
           "source": "opus"
         },
         "prompts_provided": {
           "applies": true,
           "answer": false,
           "justification": "No prompts or system instructions used in the WiNEval-3.0 evaluation are provided. The evaluation setup is described only at a high level.",
           "source": "opus"
         },
         "hyperparameters_reported": {
           "applies": true,
           "answer": false,
           "justification": "No inference hyperparameters (temperature, top-p, max tokens) are reported. Only concurrency levels are varied.",
           "source": "opus"
         },
         "scaffolding_described": {
           "applies": false,
           "answer": false,
           "justification": "No agentic scaffolding is used. Models are evaluated via direct inference.",
           "source": "opus"
         },
         "data_preprocessing_documented": {
           "applies": true,
           "answer": false,
           "justification": "No description of how WiNEval-3.0 tasks were constructed, selected, or preprocessed. The benchmark's composition is described only at a high level ('10 core scenarios').",
           "source": "opus"
         }
       },
       "data_integrity": {
         "raw_data_available": {
           "applies": true,
           "answer": false,
           "justification": "No raw data is available. WiNEval-3.0 is proprietary and not released. Only aggregated results in tables are provided.",
           "source": "opus"
         },
         "data_collection_described": {
           "applies": true,
           "answer": false,
           "justification": "WiNEval-3.0 is described as covering '10 core scenarios' from 'real clinical applications' but the actual data collection procedure is not documented.",
           "source": "opus"
         },
         "recruitment_methods_described": {
           "applies": false,
           "answer": false,
           "justification": "No human participants. Data is a benchmark of medical tasks, not a human study.",
           "source": "opus"
         },
         "data_pipeline_documented": {
           "applies": true,
           "answer": false,
           "justification": "The pipeline from task execution to cost calculation is outlined (Sections 3-4) but the construction of WiNEval-3.0 itself and any filtering or curation steps are not documented.",
           "source": "opus"
         }
       },
       "contamination": {
         "training_cutoff_stated": {
           "applies": true,
           "answer": false,
           "justification": "No training data cutoff dates are stated for any of the models tested.",
           "source": "opus"
         },
         "train_test_overlap_discussed": {
           "applies": true,
           "answer": false,
           "justification": "No discussion of whether WiNEval-3.0 data could have appeared in any model's training data. Particularly concerning for WiNGPT models which are developed by the same company.",
           "source": "opus"
         },
         "benchmark_contamination_addressed": {
           "applies": true,
           "answer": false,
           "justification": "WiNEval-3.0 is a proprietary benchmark from Winning Health, and WiNGPT models are also from Winning Health. The obvious contamination risk — that WiNGPT may have been trained or validated on WiNEval data — is never addressed.",
           "source": "opus"
         }
       },
       "human_studies": {
         "pre_registered": {
           "applies": false,
           "answer": false,
           "justification": "No human participants in this study.",
           "source": "opus"
         },
         "irb_or_ethics_approval": {
           "applies": false,
           "answer": false,
           "justification": "No human participants in this study.",
           "source": "opus"
         },
         "demographics_reported": {
           "applies": false,
           "answer": false,
           "justification": "No human participants in this study.",
           "source": "opus"
         },
         "inclusion_exclusion_criteria": {
           "applies": false,
           "answer": false,
           "justification": "No human participants in this study.",
           "source": "opus"
         },
         "randomization_described": {
           "applies": false,
           "answer": false,
           "justification": "No human participants in this study.",
           "source": "opus"
         },
         "blinding_described": {
           "applies": false,
           "answer": false,
           "justification": "No human participants in this study.",
           "source": "opus"
         },
         "attrition_reported": {
           "applies": false,
           "answer": false,
           "justification": "No human participants in this study.",
           "source": "opus"
         }
       },
       "cost_and_practicality": {
         "inference_cost_reported": {
           "applies": true,
           "answer": true,
           "justification": "Inference cost is the central topic. Table 2 reports cost per model for the full test set. Section 3 derives GPU hourly cost (~$0.79/hour for A800).",
           "source": "opus"
         },
         "compute_budget_stated": {
           "applies": true,
           "answer": true,
           "justification": "Hardware is specified as A800 80G × 2 cards. Total execution times per model and concurrency level are reported in Appendix B.",
           "source": "opus"
         }
       },
       "experimental_rigor": {
         "seed_sensitivity_reported": {
           "applies": true,
           "answer": false,
           "justification": "No multiple-seed results reported. The paper acknowledges 'model generation has some inherent randomness' (Appendix B) but does not run multiple seeds.",
           "source": "opus"
         },
         "number_of_runs_stated": {
           "applies": true,
           "answer": false,
           "justification": "The number of experimental runs is never stated. Results appear to be from single runs.",
           "source": "opus"
         },
         "hyperparameter_search_budget": {
           "applies": false,
           "answer": false,
           "justification": "No hyperparameter search is conducted. Only concurrency levels are varied, which is a system configuration rather than model hyperparameter tuning.",
           "source": "opus"
         },
         "best_config_selection_justified": {
           "applies": true,
           "answer": true,
           "justification": "Section 6.1 explicitly states the selection criterion: 'find the concurrency setting with the lowest cost (i.e., shortest total completion time) while meeting the performance baselines (e.g., throughput > 20 tokens/s and latency < 1s).' All configurations are shown in Appendix B.",
           "source": "opus"
         },
         "multiple_comparison_correction": {
           "applies": false,
           "answer": false,
           "justification": "No statistical tests are performed, so multiple comparison correction is not applicable.",
           "source": "opus"
         },
         "self_comparison_bias_addressed": {
           "applies": true,
           "answer": false,
           "justification": "Winning Health evaluates their own WiNGPT models on their own WiNEval-3.0 benchmark and finds WiNGPT-3.5 is the 'overall leader.' No acknowledgment of self-evaluation bias.",
           "source": "opus"
         },
         "compute_budget_vs_performance": {
           "applies": true,
           "answer": true,
           "justification": "Performance as a function of concurrency (a compute variable) is reported for every model in Appendix B. The Pareto frontier (Figure 1) plots quality vs. cost.",
           "source": "opus"
         },
         "benchmark_construct_validity": {
           "applies": true,
           "answer": false,
           "justification": "WiNEval-3.0 is introduced as a 'professional evaluation set for the medical field' with representative properties, but no construct validity analysis is provided. The paper does not discuss whether WiNEval-3.0 scores actually measure clinical utility.",
           "source": "opus"
         },
         "scaffold_confound_addressed": {
           "applies": false,
           "answer": false,
           "justification": "No scaffolding is involved. Models are evaluated via direct inference.",
           "source": "opus"
         }
       },
       "data_leakage": {
         "temporal_leakage_addressed": {
           "applies": true,
           "answer": false,
           "justification": "No discussion of when WiNEval-3.0 tasks were created relative to model training periods.",
           "source": "opus"
         },
         "feature_leakage_addressed": {
           "applies": true,
           "answer": false,
           "justification": "No discussion of whether the evaluation setup leaks information. For WiNGPT models tested on their own company's benchmark, this is particularly relevant.",
           "source": "opus"
         },
         "non_independence_addressed": {
           "applies": true,
           "answer": false,
           "justification": "No discussion of whether WiNEval-3.0 tasks overlap with WiNGPT training data or share structural similarities.",
           "source": "opus"
         },
         "leakage_detection_method": {
           "applies": true,
           "answer": false,
           "justification": "No leakage detection or prevention methods are applied.",
           "source": "opus"
         }
       }
     }
   },
   "claims": [
     {
       "claim": "Increasing concurrency from 8 to 48 reduces total completion time from 2034s to 774s before saturation.",
       "evidence": "Table 4: WiNGPT-3.5 (8 conc: 2034.05s, 48 conc: 774.11s); multiple models follow pattern (Seed-OSS: 2134.78s→671.64s; Qwen3: 1381.05s→739.24s)",
       "supported": "strong"
     },
     {
       "claim": "WiNGPT-3.5 achieves the best cost-quality balance (76.2% score, $0.34 cost).",
       "evidence": "Table 2 shows WiNGPT-3.5 highest quality score among all 9 models evaluated and lowest cost except gpt-oss-20b ($0.11). Benchmark-specific; empirically true for WiNEval-3.0.",
       "supported": "moderate"
     },
     {
       "claim": "Diminishing returns to scale exist in LLM inference.",
       "evidence": "Section 6.1 shows throughput increases then drops at high concurrency; marginal benefit diminishes. However, 'returns to scale' is economic jargon—paper demonstrates saturation/diminishing throughput gains, not classical returns-to-scale analysis.",
       "supported": "weak"
     },
     {
       "claim": "WiNGPT-3.0's high cost ($3.47) reflects reasoning capability producing 4–8× more output tokens than other models.",
       "evidence": "Table 2: WiNGPT-3.0 generates 4,787,928 total tokens vs. others' ~1.6–2.3M tokens. Explicitly framed as 'thinking model' with detailed chain-of-thought output. Cost correlation with output length is strong.",
       "supported": "strong"
     },
     {
       "claim": "Cost scales with model size, performance configuration, and output length.",
       "evidence": "Larger models (Seed-OSS 36B vs. Mistral-Small 24B) generally cost more. Output token counts directly correlate with cost (equations 3–4). Shown empirically across all models in Table 4.",
       "supported": "strong"
     },
     {
       "claim": "WiNEval-3.0 exhibits 'representative economic load characteristics' reflecting real-world medical applications.",
       "evidence": "Section 4 states: long-tail task length distribution, stable input/output sizes, concurrent execution capability, quantifiable per-task cost. Assertion not validated against real production workloads.",
       "supported": "moderate"
     }
   ],
   "methodology_tags": [
     "empirical",
     "benchmark-eval",
     "observational"
   ],
   "key_findings": "The paper presents a framework for analyzing LLM inference economics across three dimensions (performance, quality, cost) using the WiNEval-3.0 medical benchmark. Key empirical findings: (1) concurrency has an optimal saturation point (~48 requests) where further parallelization increases latency and overhead; (2) no single 'best' model exists—each achieves different cost-quality trade-offs at optimal configuration; (3) WiNGPT-3.5 achieves the best cost-quality balance (76.2% score, $0.34 test set cost), while specialized models like WiNGPT-3.0 sacrifice cost for reasoning depth (4–8× more output tokens); (4) cost structure is dominated by output length and can be predicted from model behavior. Framework enables data-driven GPU procurement and model selection for medical deployment scenarios.",
   "red_flags": [
     {
       "flag": "Undisclosed conflict of interest",
       "detail": "Authors develop WiNGPT models being evaluated; WiNGPT-3.5 scores highest. No competing interests statement despite institutional incentive to favor own product. Bias risk is high."
     },
     {
       "flag": "No statistical rigor",
       "detail": "Single-run results presented as fact. No confidence intervals, significance tests, or variance reporting. Acknowledged in limitations ('Lack of statistical confidence analysis') but not mitigated."
     },
     {
       "flag": "Minimal engagement with prior work",
       "detail": "Only 8 citations, no related work section. No comparison to prior economics frameworks, cost analyses, or scaling laws literature. Paper stands isolated from broader research conversation."
     },
     {
       "flag": "Benchmark-specific generalization",
       "detail": "All conclusions derive from single medical benchmark (WiNEval-3.0). Title suggests general inference economics; findings are domain-specific. Generalization risk high."
     },
     {
       "flag": "Limited reproducibility",
       "detail": "No code released, no detailed environment specs, no step-by-step instructions. WiNEval-3.0 availability unstated (proprietary?). Appendix B shows results but not how to generate them."
     },
     {
       "flag": "Potential data contamination unaddressed",
       "detail": "Training cutoff dates not provided for models. WiNEval-3.0 as 'professional medical benchmark' likely available pre-training. Train/test overlap not discussed or assessed."
     },
     {
       "flag": "No ablation studies",
       "detail": "Only concurrency varied. Cannot isolate drivers of cost (model size, tokenizer efficiency, architecture, quantization). Paper acknowledges quantization affects cost but doesn't test it."
     },
     {
       "flag": "Vague about benchmark specification",
       "detail": "WiNEval-3.0 described as covering '10 core scenarios' but specific task design, creation methodology, and whether benchmark is public/proprietary not clarified."
     }
   ],
   "cited_papers": [
     {
       "title": "Language Models Are Few-Shot Learners",
       "authors": "Brown et al.",
       "year": 2020,
       "relevance": "Foundational GPT-3 paper; cited as baseline LLM work in inference economics context."
     },
     {
       "title": "Llama 2: Open Foundation and Fine-Tuned Chat Models",
       "authors": "Touvron et al.",
       "year": 2023,
       "relevance": "Major open-source LLM; one of the baseline models in inference comparison ecosystem."
     },
     {
       "title": "Judging LLM-as-a-Judge with MT-Bench and Chatbot Arena",
       "authors": "Zheng et al.",
       "year": 2023,
       "relevance": "LLM evaluation methodology; relevant to benchmark design and quality assessment practices."
     },
     {
       "title": "Carbon Emissions and Large Neural Network Training",
       "authors": "Patterson et al.",
       "year": 2021,
       "relevance": "Scaling and efficiency analysis; foundational for cost-computation relationship in deep learning."
     },
     {
       "title": "Scaling Laws for Neural Language Models",
       "authors": "Kaplan et al.",
       "year": 2021,
       "relevance": "Empirical scaling laws; directly relevant to model size vs. performance trade-offs discussed in paper."
     },
     {
       "title": "Training Compute-Optimal Large Language Models",
       "authors": "Hoffmann et al.",
       "year": 2022,
       "relevance": "Chinchilla scaling laws; relevant to cost-optimal model configuration analysis."
     },
     {
       "title": "Efficient Memory Management for Large Language Model Serving with PagedAttention",
       "authors": "Kwon et al.",
       "year": 2023,
       "relevance": "vLLM inference framework; directly used in experiments but not cited for methodology details."
     }
   ],
   "engagement_factors": {
     "practical_relevance": {
       "score": 3,
       "justification": "Direct application: medical institutions can use framework for GPU procurement decisions, model selection for clinical workflows, and cost-benefit analysis. Concrete dollar figures and deployment configurations provide actionable guidance."
     },
     "surprise_contrarian": {
       "score": 1,
       "justification": "Findings are unsurprising: Pareto frontiers exist, larger/better models cost more, concurrency helps until saturation. No major contradictions to conventional wisdom. WiNGPT-3.5 winning its own evaluation is expected, not surprising."
     },
     "fear_safety": {
       "score": 0,
       "justification": "Purely economical analysis. No safety, alignment, hallucination, or AI risk concerns raised. No discussion of risks from medical AI deployment or model reliability in clinical contexts."
     },
     "drama_conflict": {
       "score": 1,
       "justification": "Potential conflict of interest (authors develop winning model) but not dramatized. Paper frames WiNGPT-3.0 positively ('thinking model' serving specialized needs) to mitigate appearance of bias. Minimal narrative tension."
     },
     "demo_ability": {
       "score": 2,
       "justification": "Cost calculation formulas reproducible with provided data. But full evaluation requires access to WiNEval-3.0 (availability unclear) and model APIs. Cannot fully replicate without proprietary benchmark and models."
     },
     "brand_recognition": {
       "score": 1,
       "justification": "Winning Health AI Research is lesser-known healthcare/medical AI company. WiNGPT is not established brand like OpenAI, DeepSeek, or Meta. Limited prestige amplification; narrow healthcare domain limits visibility in general AI community."
     }
   },
   "hn_data": {
     "threads": [
       {
         "hn_id": "46714925",
         "title": "SlimEdge: Lightweight Distributed DNN Deployment on Constrained Hardware",
         "points": 1,
         "comments": 0,
         "url": "https://news.ycombinator.com/item?id=46714925",
         "created_at": "2026-01-22T03:27:40Z"
       }
     ],
     "top_points": 1,
     "total_points": 1,
     "total_comments": 0
   }
 }